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Abstract: 
Objectives: Whereas high frequency-repetitive Transcranial Magnetic Stimulation (HF-rTMS) 
over the left dorsolateral prefrontal cortex (DLPFC) has been reported to improve mood 
symptoms in Major Depression (MDD), research on its impact on psychomotor symptoms is 
scarce. This study assessed the psychomotor effects of respectively one and ten sessions of 
HF-rTMS over the left DLPFC.   
Methods: Ten HF-rTMS sessions were applied in 21 medication-free MDD patients over a 2 
week-period. At the beginning, one placebo (sham) -controlled rTMS session was also 
applied in a crossover, single-blind design. Psychomotor variables were digitally recorded 
during completion of a Fitts task, at baseline, after the first and second real/sham session, and 
at endpoint.  
Results: The total 10 session-treatment period resulted in a decrease of depression severity. 
One HF-rTMS-session resulted in improvements on the Fitts task, however without a 
difference between active and sham stimulation. No further improvements occurred from 
session 2 to 10. 
Conclusions: No evidence was provided to link the observed psychomotor improvements to 
HF-rTMS stimulation, as a practice effect could have impacted the significant psychomotor 
outcomes.  
 
Key words: transcranial magnetic stimulation, HF-rTMS, psychomotor symptoms, 
retardation, major depressive disorder 
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Introduction 
Last years, studies investigating the therapeutic efficacy of repetitive Transcranial Magnetic 
Stimulation (rTMS) for Major Depressive Disorder (MDD) have exponentially increased [1-
3]. A growing body of evidence has been published indicating that depressed patients can be 
successfully treated with high-frequency (HF)-rTMS when administered on the left prefrontal 
cortex [4-6]. Recent meta-analytic studies support the antidepressant efficacy of this 
technique in treatment-resistant depressed patients when stimulation periods are long enough 
(e.g. >2 weeks) [2-3]. Besides the treatment duration, frequency and side of stimulation 
should also be taken into account when evaluating the efficacy of rTMS [3].  
Most rTMS studies focussed on the reduction in mood symptoms in MDD, whereas effects of 
rTMS on psychomotor functioning have been rarely explored.  
Notwithstanding, cognitive dysfunctions and psychomotor retardation have also been 
determined as core features of a major depressive episode [7-9]. Psychomotor slowing 
appears to be a strong diagnostic marker for MDD with melancholic features. As 
psychomotor retardation is one of the key symptoms of the melancholic subtype of 
depression, a cohort of melancholic patients would be very appropriate to investigate 
psychomotor changes following rTMS treatment. From a neurobiological perspective, 
psychomotor retardation in major depression -and especially the melancholic subtype- has 
been linked to a hypodopaminergic state [7,9]. Moreover, prefrontal rTMS has been found to 
influence striatal dopaminergic activity [10-11]. Furthermore, a higher level of psychomotor 
retardation has been associated with reduced metabolic activities in the left dorsolateral 
prefrontal cortex (DLPFC) suggesting an important role of this cortical area on psychomotor 
functioning [9]. Therefore, given the possible neurobiological and clinical implications, a 
thorough investigation of the psychomotor effects of rTMS in MDD is warranted.  
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A limited number of studies already examined the neurocognitive effects of rTMS in MDD 
[12-13], but even fewer studies examined the impact of rTMS on psychomotor performance 
in MDD. Applying the Motor Agitation and Retardation Scale (MARS), Hoeppner et al. [14] 
observed a reduction in psychomotor retardation following 10 HF-rTMS sessions over the left 
dorsolateral prefrontal cortex, whereas the same authors [15] could only demonstrate a trend 
in the reduction of psychomotor agitation but not for retardation in MDD following 15 left 
prefrontal HF-rTMS sessions. Finally, Baeken et al. [16] demonstrated a positive effect of 10 
sessions of HF-rTMS on psychomotor slowing as measured by means of the Salpêtrière 
Retardation Rating Scale (SRRS). 
Given the limited number of studies on this subject and their divergent results, the current 
study further investigated the psychomotor effects of HF-rTMS in MDD, applying the Fitts’ 
task. This computerized task is an objective and reliable method to assess fine motor activity, 
and is generally considered to be a rater-independent and more objective measurement 
method than the more subjective rating scales [9]. The Fitts’ task has been widely used in the 
research into psychomotor symptoms in MDD [17-19]. This fine motor task requires a precise 
sensori-motor programming, initiation and execution of the muscle commands [17-19] and 
one HF-rTMS session with parameters comparable to rTMS treatment for depression has been 
reported to affect this psychomotor functioning in healthy subjects [20]. 
Consequently, the present study aims to further explore the psychomotor effects of HF-rTMS 
over the left DLPFC in a sample of medication resistant MDD patients, applying the Fitts’ 
task. To evaluate the effect of a single stimulation on psychomotor functioning, we assessed 
the effects of one sham-controlled session of HF-rTMS delivered on the left DLPFC, in a 
single blind placebo controlled crossover design. To examine the effect of HF-rTMS 
treatment, the effect on the Fitts’ task was assessed after10 such sessions spread over a period 
of 2 weeks of treatment. To ascertain that the melancholic depressed patients displayed 
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decreased psychomotor speed, their baseline Fitts’ measurements were compared to an age 
and gender matched control group. 
As mentioned above, few studies on psychomotor effects in MDD have been executed up to 
now, psychomotor retardation has been associated with DLPFC hypofunction and a 
hypodopaminergic state, and rTMS has been supposed to exert an impact on the dopaminergic 
system. Together with the limited existing evidence mentioned above, all these findings make 
us hypothesize that an improvement in psychomotor functioning could be expected after HF-
rTMS treatment especially in our treatment responder group.  
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1. Methods 
2.1. Patients 
Our group consisted of twenty-one medication-free unipolar depressed patients of the 
melancholic subtype (female:male =13:8; age 44.7 ± 10.3 years). Psychiatric disorders were 
assessed using the Mini-International Neuropsychiatric Interview (MINI) [21]. Because 
concomitant personality disorders were not part of the exclusion criteria no formal diagnostic 
screening on axis II diagnosis was performed. Severity of depression was assessed with the 
21-item Beck Depression Inventory (BDI) [22] and the 17-item Hamilton Depression scale 
(HDRS) [23]. The HDRS was administered by an experienced psychiatrist, not related to the 
study. Eleven participants were current in-patients during HF-rTMS treatment. Treatment 
resistance was assessed with the Thase and Rush criteria [24]. All were right-handed and 
considered at least stage III treatment resistant: they had had a minimum of two unsuccessful 
trials of SSRI/NSRI treatment and one failed trial with tricyclic antidepressants (TCA) as 
described by Rush et al. [25]. Because concomitant antidepressant treatment can confound 
outcome results, all patients went through a two week antidepressant washout before entering 
the study (3 weeks if they were on fluoxetine). Where necessary, patients were kept on a 
steady dose of their ‘somatic’ medications. During the washout period patients had contact 
with their physicians on a regular basis. Only habitual benzodiazepine agents were allowed: 
one subject took alprazolam (1mg), one clonazepam (0.5mg), one flunitrazepam (1mg), and 
one took alprazolam (1mg) and flurazepam (27mg). During our stimulation protocol, all 
psychopharmacological changes were considered as drop-out from the study. Additionally, no 
changes of habitual somatic treatment were allowed. All subjects underwent physical, 
neurological (MRI, EEG) and psychiatric examinations.  
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Exclusion criteria were current or past history of epilepsy, neurosurgery, having metal or 
magnetic objects in the brain, and being pregnant. Patients with suicide attempts during the 
current depressive episode or alcohol/drug dependence and/or abuse, were not included. 
A group of 28 healthy controls (mean age: 40.82 +/- 6.93; male:female ratio= 11/17) was 
included matched for sex and age with the patient group (p=0.20 and p=0.77, respectively). 
These controls were recruited in the context of a previous research project on psychomotor 
functioning in major depression [26]. This study was part of a larger project investigating the 
influence of HF-rTMS on different neuro-cognitive markers. The study was carried out 
consistent with the latest version of the Helsinki Declaration and was approved by the ethics 
committee of the University Hospital (UZBrussel) of the Vrije Universiteit Brussel (VUB). 
All subjects gave written informed consent.  
 
2.2. Psychomotor assessments 
 
For the objective psychomotor measurement, all participants carried out a Fitts’ task (see 
Figure 1) using a pressure-sensitive inking ballpoint pen on sheets of paper placed on a 
digitizer that was connected to a personal computer. The Fitts task is a computerized fine 
motor task that has been designed especially to evaluate sensorimotor programming, initiation 
and execution of the muscle commands, without requiring higher-order cognitive processes 
[17-19]. In this task subjects had to connect two vertically placed circles, depicted on a 
normal sheet of paper, by drawing a line of about one cm. They were instructed to start in the 
middle of the top circle and to end in the middle of the lower circle. Per trial six lines had to 
be drawn. The accuracy of movement was varied by changing the circle diameter from 0.50 
cm in trials 1 and 4 (Figure 1, upper part) to 0.25 cm in trials 2 and 3 (Figure 1, lower part). 
Movement time (MT) was recorded, i.e. the time between the start and the completion of each 
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separate line drawing movement. The movement times of inaccurate line drawings, i.e. when 
the line was drawn from the lower to the upper circle and/or when the start/endpoint of the 
connecting line was situated outside the circle diameter, were not included in the analyses. 
 In addition, visual analogue scales (VAS) were used to examine subjective mood changes:  
subjects were asked to rate their mood on five horizontal 100 mm VAS in order to detect 
subtle changes in feelings of ‘depression’, ‘fatigue’, ‘tension’, ‘anger’ and ‘vigor’ . The 
minimum score on each VAS subscale is 0 and the maximum score is 100. Right-handedness 
was assessed with the Van Strien Questionnaire [27]. 
 
--Insert Figure 1 about here-- 
 
2.3. Design and rTMS procedure 
Patients underwent 10 sessions of HF-rTMS on the left DLPFC within a period of 2 weeks. 
At the beginning of this open treatment trial, each subject received also one placebo (sham) 
HF-rTMS stimulation session, separated 1 day from the first active stimulation session. This 
phase was a placebo-controlled crossover, single-blind design allowing examination of a 
single session, specific rTMS effects in MDD patients. 
Potential mood changes were assessed before (Tpre), immediately after (Tpost) and 
30 min after (Tpost30) terminating the first rTMS (real/sham) session, using VAS scales. 
Antidepressant effects of 2 weeks of rTMS treatment were investigated by assessing the 
HDRS and BDI at baseline and endpoint, i.e. after the eleventh stimulation session (of which 
one was a placebo session). The Fitts task was applied before (Tpre: before the first session 
real or sham) and immediately after (Tpost) terminating the first and second rTMS (real and 
sham) session, and at the end of the rTMS treatment period (Tpost-treatment: after the last 
session).  
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Because this study is part of a larger project investigating the influence of HF-rTMS on 
different neuro-cognitive markers, additional tasks were also administered that were not used 
for the purposes of the present study. All measures were always presented in the same order 
for all participants.     
Patients were kept unaware of the type of stimulation; they wore earplugs and were 
blindfolded. Importantly, all patients were stimulated on all occasion within the same time 
schedule, i.e. between 10 am and noon.  
For the application of rTMS we used a Magstim high-speed magnetic stimulator (Magstim 
Company Limited, Wales, UK), connected to a figure-of-eight-shaped coil. Before each 
application, the motor threshold (MT) of each individual was determined using 
electromyography (EMG). A stimulation intensity of 110 % of the subject’s motor threshold 
of the right abductor pollicis brevis muscle was used. In order to accurately target the left 
dorsolateral prefrontal cortex (Brodmann area 9/46), the precise stimulation site and position 
of the coil were determined using MRI non-stereotactic guidance (Philips Intera, Best, The 
Netherlands). Perpendicular to this point, the precise stimulation site on the skull was marked 
and stimulated [28]. In each high-frequency (10 Hz) stimulation session, subjects received 
forty trains of 3,9 s duration, separated by an intertrain interval of 26.1 s. Each session, 
therefore, lasted 20 minutes (1560 pulses per session). For the sham condition, the coil was 
held at an angle of 90°, with one edge only resting on the scalp. The International Society of 
Transcranial Magnetic Stimulation (ISTS) safety guidelines were followed [29-30].  
2.4. Statistics  
All results were analysed using the SPSS for Windows 16.0 software package. Statistical 
analyses were performed using ANOVA’s. The significance level was set at p<0.05 for all 
analyses. Baseline and endpoint psychomotor outcomes in the patient group were compared 
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with the outcomes of an age- and gender-matched control group that participated in a previous 
research project in which psychomotor measurements were registered [26]. Separate analyses 
were conducted to investigate the single session effect (1 active/sham session) and the 
treatment effect (10 active sessions) of HF-rTMS. 
Regarding the single session effects, we used separate 3X2 ANOVA’s with the VAS mood 
scales as dependent variables and Session (Tpre, Tpost, Tpost30) and Stimulation (active or 
sham) as within-subject factors. With regard to the analyses for the single session effects on 
the Fitts task, a 2X2X2 factorial design was used with Stimulation (active, sham), Session 
(Tpre, Tpost) and Complexity [small vs. large circles] as within-subject factors.  
Subsequently, overall improvement in HDRS and BDI-scores between the baseline and final 
assessment were analysed using paired t-tests over the whole group. Clinical response was 
defined as a 50% reduction of the baseline HDRS score. 
A similar 2X2X2 design was applied for the psychomotor outcomes related to the 10 session 
treatment with Session (Tpre, Tpost-treatment) and Complexity (small vs. large circles) as 
within-subject factors, and Treatment Response (responders, non-responders) as between-
group factor. 
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2. Results 
2.1.Baseline psychomotor outcomes 
A comparison of the baseline Fitts outcomes of the patient group with those of an age- and 
gender-matched control group (mean RT: 255 msec; SD: 0.25) pointed to a significantly 
slower performance of the patients (mean RT: 321 msec; SD: 0.12; t=2.21, p <0.05). 
 
2.2. Single session effects 
Mood 
VAS analyses were conducted on 20 patients because one subject had numerous missing 
values. The separate ANOVAs did not reveal any significant effect, neither for the main effect 
of Stimulation [all F-values <1.33] or Session [all F-values<2.45], nor for the Stimulation by 
Session interaction [all F-values<1.09]. The only exception was the VAS depression subscale 
that showed a main effect of Session [F(2,18)=8.38, p<0.01] with the scores slightly 
decreasing from Tpre (6.46) over Tpost (5.12) to Tpost30 (5.74), however without a 
significant Stimulation by Session interaction [F<1].  
 
Psychomotor variables 
As demonstrated in previous studies, a smaller diameter of the circles resulted in significantly 
higher MTs [F(1,20)=94.6, p<0.001]. Moreover, a significant main effect of Session was 
found with the MTs improving from pre to post-stimulation [F(1,20)=5.68, p<0.05; Tpre: 309 
ms, Tpost: 284 ms]. However, neither the Stimulation by Session interaction nor any of the 
other interactions were significant [all Fs<1], with the exception of the Complexity by Session 
interaction [F(1,20)=3.91, p<0.1]. These results indicate that the first rTMS session did 
improve fine motor performance but no difference could be demonstrated between active (T 
pre: 306msec; T post: 279msec) or sham (T pre: 311msec; T post: 287msec) stimulation 
Impact of HF rTMS on fine motor functions in MDD 
 12
within that time frame.  It should be noted that patients remained slower than healthy controls 
after the first stimulation session (F=3.14, p<0.1). 
 
2.3.Treatment effects 
Mood 
Mean HDRS scores before entering the study were 25.24 (SD= 3.9) and mean BDI scores 
were 33.82 (SD= 12.19), indicating severe depression. The overall patient group demonstrated 
a significant improvement in HDRS and BDI-scores between the baseline and final 
assessment [final HDRS: 15.35, t=5.61, p<0.001; final BDI: 25.27, t=2.76, p<0.05]. Eleven 
patients (52%) were considered as clinical non-responders, and the other ten (48%) as clinical 
responders.  
 
Psychomotor variables 
A significant psychomotor improvement was observed from baseline to endpoint [Tpre: 
321ms, Tpost-treatment: 276ms; F(1,19)=4.22, p<0.05], as well as the well known effect of 
Complexity [F(1,19)=80.88, p<0.001]. Neither the main effect of nor any interactions with 
Treatment Response were significant [Fs<2.12]. 
A comparison of the endpoint Fitts outcomes of the patient group (mean RT: 276 msec) with 
the baseline data of the control group (mean RT: 255 msec) did not reveal any significant 
differences in psychomotor performance anymore (t=0.78, p=0.44). 
Note that no further substantial psychomotor improvements occurred between session 2 
(which was an HF-rTMS or a Sham session) and session 10 (last HF-rTMS session): F<1, 
p=0.36. This could implicate that the observed psychomotor improvements are obtained 
between the first and the second psychomotor assessment (following 1 sham/rTMS 
stimulation), which further underscores the previously mentioned impact of a practice effect. 
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Additional correlational analyses were conducted to further investigate the association 
between the clinical and psychomotor variables. No significant correlations could be observed 
neither between the absolute difference of the baseline and endpoint rTMS psychomotor 
variable and the absolute difference in HDRS/BDI scores, nor between the proportional 
changes of mentioned variables (all r values <0.34, all p values >0.15). In this context, it 
should also be mentioned that the Fitts outcomes at baseline and endpoint did not correlate 
with the duration of the current episode or the stage of treatment resistance (all r-values < 
0.19, all p values >0.4).  
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3. Discussion 
The current study explored the clinical and psychomotor effects of respectively one sham-
controlled and ten active HF-rTMS sessions in treatment resistant major depression applying 
clinical rating scales and an objective psychomotor assessment method, i.e. the Fitts’ task.  
At baseline MDD patients performed significantly slower than an age- and gender-matched 
control group, which has also been demonstrated repeatedly in previous studies from our 
research group [9].The total patient sample manifested a clear improvement in depression 
severity following 10 active rTMS sessions with approximately half of the patient sample 
manifesting a clear clinical response, as determined with a 50% decrease of the initial HDRS 
scores, which is in line with previous HF-rTMS treatment studies in MDD [31]. Regarding 
the VAS, one HF-rTMS session did decrease the depression subscale scores, however 
irrespective of the stimulation type (active or sham). Scores on the other VAS subscales did 
not significantly change following one session.  
Focussing on the effects of one HF-rTMS-session, psychomotor improvements were observed 
on the Fitts’ task, however without revealing a difference between active and sham 
stimulation. The analyses investigating the total treatment period of 10 HF-rTMS sessions did 
point to a better endpoint performance on the Fitts’ task, but these psychomotor 
improvements are likely due to a practice effect on the task. Indeed, the psychomotor 
improvements observed after session one emerged irrespective of sham or active HF-rTMS 
stimulation, and no further improvements occurred from session 2 to session 10. 
Notwithstanding, it should be mentioned that for every assessment session patients were given 
the opportunity to practice with and get used to the task, before the proper recordings started. 
Besides the mentioned practice effect, it might be possible that due to certain non-specific 
aspects related to the rTMS procedure such as its impressive name, its discomfort, and its 
sophisticated-looking equipment a placebo effect could have influenced the one session 
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outcomes [32]. In addition, we cannot totally rule out a possible impact of our sham control 
condition: although this sham condition was performed at a 90° angle, ensuring minimal 
stimulation of the DLPFC, it still could be possible that a partially active placebo was used 
[33]. 
Whereas the current study mainly focused on fine motor performance, it would also be 
interesting to obtain more knowledge on the effects of rTMS on gross motor performance. 
However, the relationship between gross and fine motor performance in MDD has not yet 
been elucidated and it is not clear whether MDD patients with fine motor dysfunction are 
affected to the same degree in their gross motor performance [9]. Therefore, in order to 
investigate the impact of rTMS on gross motor performance, a similar rTMS design should be 
executed with assessment methods of gross motor activity such as actometric measurements.  
In addition, most previous studies have examined the psychomotor effects of rTMS treatment 
applying clinical rating scales.  Hoeppner and colleagues reported a significant improvement 
of baseline MARS-rated psychomotor retardation after 10 HF-rTMS sessions spread over 2 
weeks for both a group treated with 20Hz HF-rTMS as a group treated with 1Hz HF-rTMS, 
whereas a sham group did not manifest any psychomotor improvement [14]. In another study 
however, Hoeppner et al. could not demonstrate a beneficial effect of left prefrontal 10Hz HF-
rTMS treatment during 15 days on MARS assessed psychomotor retardation [15]. Instead, 
they found nearly significant reductions in the agitation symptoms. Very recently, Baeken et 
al. reported a decrease in SRRS scores after 10 sessions of 10 Hz HF-rTMS over the left 
DLPFC [16]. In this context, it needs to be mentioned that rating scales and the applied 
psychomotor assessment method substantially differ in their duration of observation: rating 
scales are based on prolonged clinical observations whereas experimental tasks just capture 
fine motor performance during task execution [9]. Moreover, rating scales can be rater-
dependent whereas the currently used assessment method does not depend on the rater [9]. 
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A limitation of the current study could be the number of HF-rTMS sessions. In spite that 
rTMS treatment parameters are quite intense, the duration of two weeks might be considered 
as rather short. Indeed, current HF-rTMS treatment protocols stimulate patients three to six 
weeks daily [6, 34]. Further, as a higher level of treatment resistance in the current depressive 
episode might be inversely related to clinical outcome, this might to some extent have 
impacted our fine motor task results [35].  
A major strength of the present study is that all patients had a sufficient washout period from 
their antidepressants, whereas in several other studies patients were still taking their current 
psychotropic medication. Moreover, during the stimulation protocol, no changes to the 
patients’ habitual somatic treatment were allowed. On the other hand, although all included 
patients in our analysis continued with exactly the same benzodiazepine concentrations, the 
use of benzodiazepines in our sample might have been a confounding variable [19]. 
Future studies might do well to further objectively investigate fine motor functioning in 
depressed samples in association with rTMS treatment. More intensive placebo-controlled 
rTMS studies are needed to further disentangle the effect of HF-rTMS on the psychomotor 
system as clinical improvement with these kinds of techniques are reported.
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Figure 1: Fitts task  
 
 
 
 
 
 
Figure 2: Mean movement times (in msec) of the patient group from baseline to endpoint for 
the Fitt’s task 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
